Patents by Inventor Li Wan Yi

Li Wan Yi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition for preventing or treating asthma comprising J. Poiss. ex Franch extract or fraction thereof
    Patent number: 10413579
    Abstract: The present invention relates to a composition for preventing or treating asthma comprising a Pistacia weinmannifolia J. Poiss. ex Franch extract or a fraction thereof. The Pistacia weinmannifolia J. Poiss. ex Franch extract or the fraction thereof according to the present invention does not exhibit toxicity, inhibits the generation of NO, IL-4, IL-5, and IL-13 and the generation of reactive oxygen species in the bronchial tubes, and has significantly induced the alleviation of airway hyperresponsiveness, inhibition of the infiltration of inflammatory cells into the bronchial tubes, and reduction of inflammatory cells in bronchoalveolar lavage fluid in an ovalbumin-induced asthma mouse model. In addition, the Pistacia weinmannifolia J. Poiss.
    Type: Grant
    Filed: July 1, 2014
    Date of Patent: September 17, 2019
    Assignee: Korea Research Institute of Bioscience and Biotechnology
    Inventors: Kyung Seop Ahn, Sei Ryang Oh, Ok Kyoung Kwon, In Sik Shin, Hyung Won Ryu, Sang Woo Lee, Joong Ku Lee, Hyeong Kyu Lee, Sang Ho Choi, Doo Young Kim, Jung Hee Kim, Li Wan Yi, Jin Hang
  • PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ASTHMA COMPRISING PISTACIA WEINMANNIFOLIA J. POISS. EX FRANCH EXTRACT OR FRACTION THEREOF
    Publication number: 20170173095
    Abstract: The present invention relates to a composition for preventing or treating asthma comprising a Pistacia weinmannifolia J. Poiss. ex Franch extract or a fraction thereof. The Pistacia weinmannifolia J. Poiss. ex Franch extract or the fraction thereof according to the present invention does not exhibit toxicity, inhibits the generation of NO, IL-4, IL-5, and IL-13 and the generation of reactive oxygen species in the bronchial tubes, and has significantly induced the alleviation of airway hyperresponsiveness, inhibition of the infiltration of inflammatory cells into the bronchial tubes, and reduction of inflammatory cells in bronchoalveolar lavage fluid in an ovalbumin-induced asthma mouse model. In addition, the Pistacia weinmannifolia J. Poiss.
    Type: Application
    Filed: July 1, 2014
    Publication date: June 22, 2017
    Inventors: Kyung Seop Ahn, Sei Ryang Oh, Ok Kyoung Kwon, In Sik Shin, Hyung Won Ryu, Sang Woo Lee, Joong Ku Lee, Hyeong Kyu Lee, Sang Ho Choi, Doo Young Kim, Jung Hee Kim, Li Wan Yi, Jin Hang